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Brief pain re-assessment provided more
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information for low-back or shoulder pain
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and D. A. W. M. van der Windt1
Abstract
Background: Research investigating prognosis in musculoskeletal pain conditions has only been moderately
successful in predicting which patients are unlikely to recover. Clinical decision making could potentially be
improved by combining information taken at baseline and re-consultation.
Methods: Data from four prospective clinical cohorts of adults presenting to UK and Dutch primary care with
low-back or shoulder pain was analysed, assessing long-term disability at 6 or 12 months and including baseline and
4–6 week assessments of pain. Baseline versus short-term assessments of pain, and previously validated multivariable
prediction models versus repeat assessment, were compared to assess predictive performance of long-term disability
outcome. A hypothetical clinical scenario was explored which made efficient use of both baseline and repeated
assessment to identify patients likely to have a poor prognosis and decide on further treatment.
Results: Short-term repeat assessment of pain was better than short-term change or baseline score at predicting
long-term disability improvement across all cohorts. Short-term repeat assessment of pain was only slightly more
predictive of long-term recovery (c-statistics 0.78, 95% CI 0.74 to 0.83 and 0.75, 95% CI 0.69 to 0.82) than a multivariable
baseline prognostic model in the two cohorts presenting such a model (c-statistics 0.71, 95% CI 0.67 to 0.76 and 0.72,
95% CI 0.66 to 0.78). Combining optimal prediction at baseline using a multivariable prognostic model with short-term
repeat assessment of pain in those with uncertain prognosis in a hypothetical clinical scenario resulted in reduction in
the number of patients with an uncertain probability of recovery, thereby reducing the instances where patients may
be inappropriately referred or reassured.
Conclusions: Incorporating short-term repeat assessment of pain into prognostic models could potentially optimise
the clinical usefulness of prognostic information.
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Background
Musculoskeletal conditions account for 14% of all
general practice (GP) consultations, with a quarter of
the registered population consulting each year with a
musculoskeletal problem [1]. Regional, non-inflammatory
disorders - back, knee, neck and shoulder pain - are
among the most common problems, together representing
more than 40% of all consultations for musculoskeletal
conditions [1]. Outcome varies considerably between indi-
vidual patients [2–5] and remains difficult to predict ac-
curately despite a considerable number of published
studies deriving prognostic models [6]. This has led to un-
certainty around how to manage patients who present to
GPs with musculoskeletal pain. Such uncertainty may
result in patients being referred unnecessarily, or being
incorrectly reassured that their pain will subside when
they might in fact benefit from early treatment.
Although the methods for prognostic model research
have advanced over the past 10 years, little research has
addressed issues related to the clinical usefulness and
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impact of prognostic information. A feature of most
published studies in this field has been the reliance on
information on prognostic factors assessed at one point
in time (baseline), with prediction of future outcome
based on this one assessment only. However, prognostic
information will often include time-varying factors, and
using information from a single assessment only is
likely to result in suboptimal prognostic performance
as patients tend to consult when their symptoms are at
their worst, and short-term improvements following
the consultation are likely [7]. These short-term im-
provements in pain episodes have been described not
only in acute low back pain (e.g. [8]) but also in longer-
term pain problems [9, 10]. A single assessment also
seems out of touch with clinical practice where GPs
incorporate information from previous visits to esti-
mate prognosis and decide on treatment and referral.
When a patient first consults with musculoskeletal pain
it is not always certain whether they require immediate
referral, can be reassured that their pain will subside, or
require monitoring over time to see how the problem
develops; further information gained from repeat con-
sultations may help with such decisions. This implies
that information collected at the time of the first con-
sultation may not provide optimal prognostic informa-
tion. Indeed, it has been previously shown that
combining information on prognostic factors taken at
baseline and short-term repeated assessment [11] pro-
vided better prediction of long-term outcome in low
back pain patients than a baseline score. However, this
does not address the issue of how to manage patients
who re-attend primary care for musculoskeletal pain, or
whether brief repeated assessments of symptoms pro-
vide more information about likely future outcomes
compared to a more comprehensive baseline assess-
ment. Research to address these questions might aid
clinical decision making regarding the need for early re-
ferral and treatment in patients with a low probability
of recovery, whether monitoring of symptoms might be
helpful, or whether patients can be reassured regarding
their prognosis. The aim of this study was therefore to
explore whether the efficiency of clinical decision
making can potentially be improved by combining in-
formation taken at baseline and re-consultation, as
identifying optimal approaches to collecting prognostic
data could lead to improved estimation of long-term
outcomes, providing better information to support
treatment decisions.
We hypothesised that incorporating information from
repeated assessments of pain in prognostic models will
significantly improve prognostic performance and re-
duce uncertainty in clinical decision making when esti-
mating the likelihood of long-term outcomes in patients
consulting with musculoskeletal pain.
Specific objectives
1. To explore the prognostic performance of repeated
(4–6 week) assessment or change in pain compared
with baseline assessment only in the prediction
of longer-term (6–12 month) outcome in painful
musculoskeletal conditions, and evaluate the
consistency of the findings across different
samples;
2. To assess the prognostic performance of the
incorporation of short-term repeated assessment
of pain with data collected on multiple prognostic
factors at baseline, and assess the unique contribution
of short-term repeat assessment of pain, in the
prediction of long-term outcome;
3. To test a strategy for accurately and efficiently
classifying patients as being at low or high probability
of recovery, based on prognostic information
measured at a single point in time in combination
with a short-term repeated assessment in those at
intermediate risk of a poor prognosis at baseline.
Methods
Potentially eligible studies were identified from two
bibliographic databases held at Keele University that in-
clude the results of sensitive searches for prognosis stud-
ies in primary care. A systematic search of eligible studies
was not conducted; the aim was instead to identify studies
of different musculoskeletal conditions that met specific
criteria, allowing us to test the study hypothesis. First
authors or principal investigators of eligible studies were
contacted to ask for their collaboration and request
necessary data.
Inclusion criteria
 Design: prospective cohort study;
 Population: patients consulting with spinal pain
(back or neck), shoulder pain, or knee pain in
primary care;
 Outcome measures: pain-specific disability (e.g.
Roland-Morris Disability Questionnaire (RMDQ)
[12] or Shoulder Disability Questionnaire (SDQ)
[13]), patient-perceived recovery;
 Prognostic factor measurement: at least two
assessments of pain: at baseline and short-term
(within 4–6 weeks of baseline assessment);
 Outcome ascertainment: Longer-term follow-up
(at least 6 months after baseline assessment).
Statistical Analysis
Descriptive statistics were used to characterise each of
the study samples, present long-term outcome scores for
disability, and present short-term changes and repeat
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assessment scores in pain. Baseline and short-term pain
scores were analysed on their original scale (e.g. visual
analogue scale or 0–10 numeric rating scale [14]).
Objective 1: Comparison of repeat assessment with baseline
value
The long-term recovery outcome for objective 1 was de-
fined based on a validated cut-off point for minimal im-
portant change in disability for the RMDQ and SDQ (at
least 30% improvement [15, 16]) allowing classification of
participants into those “Improved” or “Not improved”.
For each study, pain measured at baseline was entered
into separate logistic regression models with the dichot-
omised variable for disability improvement as the out-
come measure, to investigate whether this baseline
variable predicted improvement in disability at long-
term follow-up. The same analysis was then repeated
using short-term change (difference between baseline
and shortest follow-up point from each study) and abso-
lute short-term follow-up score (repeat assessment) of
pain as predictors of disability improvement at long-
term follow-up, in separate analyses. The strength of
association (odds ratios (ORs) with 95% CI), model
goodness-of-fit (Hosmer & Lemeshow and Nagelkerke
pseudo r-square), and prognostic performance (AUC (c-
statistic)) were compared for each model [17]. A c-
statistic of 0.75 or above was considered to indicate good
discrimination (i.e. a high level of sensitivity and specifi-
city), and a value of 0.50 indicates a level of association
no better than chance [17]. Differences in c-statistics
were compared using the STATA roccomp command
[18]. A p value of <0.05 indicates a statistically signifi-
cant difference in the c-statistics.
Objective 2: Comparison of repeat assessment with
multivariable baseline prognostic model
Only datasets that had already obtained a prediction
model (van der Windt [19] and Kuijpers [20] – both
shoulder pain populations) were used in this analysis.
The outcome measure used was patient perceived re-
covery from shoulder symptoms (dichotomised: 1 = re-
covery) as used in the original prognostic model,
rather than the disability improvement scores used in
objective 1. Each of the prognostic models were re-
run to check whether they produced the same results
as the original study. Prognostic performance was
then described and compared to that of incorporating
a brief repeat assessment of pain in the same way as
in Objective 1 (Hosmer & Lemeshow test, Nagelkerke
pseudo R-square, ORs and AUC), using the STATA
roccomp command to test for statistically significant
differences in c-statistics between the models. We
also examined the contribution of repeat assessment
of pain when adding this to the original prognostic
model using an omnibus test [21] to examine whether
adding such short-term information significantly im-
proved fit of the prediction model.
Objective 3: Scenario combining optimal baseline prediction
with brief repeated assessment
The purpose of this final objective was to test a more
efficient hypothetical clinical scenario (Fig. 1) using the
Fig. 1 Clinical Scenario
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Kuijpers [20] dataset, that does not require all patients
to receive a repeat assessment. The scenario aims to dis-
criminate between those with a high probability of recovery
(i.e. likely to need advice and pain relief but no further
monitoring required) and those with a low probability of
recovery at six months (i.e. likely to require treatment or
referral). Prognostic information collected at baseline in all
patients was combined with a short-term repeat assessment
of pain in those with an intermediate probability of
recovery (uncertain prognosis). This scenario would
result in only those who GPs were most uncertain
about being asked to return for a repeat consultation,
who would then be re-assessed and a better informed
decision made based on the patient’s reporting of pain
at that second consultation.
Patient perceived recovery at six months was used as
the outcome measure (as in objective 2). Two stages of
analyses were performed to assess prognostic perform-
ance of the combined strategy:
1. Discrimination at baseline between those at low,
intermediate, and high probability of long-term
recovery using cut-points based on predicted
probabilities of recovery (scores of ≤0.33, 0.34 to
0.66, ≥0.67) from the optimal baseline prognostic
model. Cut-offs for what constituted low, intermediate
and high probability of recovery were chosen
based on consensus among the clinicians and
methodologists within the study team, given the
absence of empirically derived cut-offs in this area.
2. Discrimination at short-term follow-up in those
with intermediate probability of long-term recovery
(n = 229) by reclassification as low, intermediate,
and high probability of recovery at six months
based on the results of the full baseline model
plus a repeat assessment of pain six weeks after
their baseline assessment. Cut-off points for predicted
probabilities were the same as those used in step 1.
The results of these two stages were then compared to
assess how many patients originally allocated to the
intermediate probability (uncertain) group (stage 1) had
moved to either the high or low probability group by
short-term follow-up (stage 2), and how many of these
were correctly or incorrectly classified in terms of their
long-term outcomes.
Results
Descriptive Results
Four datasets were identified, requested and obtained
[19, 20, 22, 23]. The design and results of these studies
are summarised in Table 1. Two included patients with
low back pain and two included patients with shoulder
pain. No studies that included patients with knee pain
were considered eligible for this study. The disability
outcome measures used for these populations were the
Roland-Morris Disability Questionnaire (RMDQ) [12]
and Shoulder Disability Questionnaire (SDQ) [13] re-
spectively. All studies recruited patients from primary
care (general practice) clinics. One study [23] only in-
cluded patients who had experienced pain for a month
or less and two papers included patients with new pain
episodes [19, 20]. The Dunn study [22] included a mix
of patients with pain of short- and longer-term duration.
All studies showed mean improvement in the outcome
of disability, and 24% to 64% achieved 30% improvement
in disability at the long-term follow-up point. The studies
measured a number of different prognostic factors, includ-
ing pain duration, fear-avoidance beliefs, [20, 22, 23] pain
catastrophising [22] and pain coping [22]. Two studies
[19, 20] had previously tested prognostic models within
these datasets. Full details about the measures used in
each study can be found in Additional file 1.
Objective 1
This objective compared the performance of the differ-
ent models in predicting long-term disability outcome:
(1) baseline pain scores only, (2) short-term pain score
(repeat assessment at short-term follow-up), and (3)
short-term change in pain (change since baseline). The
Hosmer & Lemeshow tests indicated good fit for nearly
all analyses (Table 2). The Nagelkerke R2 values were
higher for the repeat assessment of pain models. The c-
statistics (AUC) also suggest that a repeat assessment of
pain at short-term follow-up best predicts the outcome
of disability improvement, followed by the short-term
change models. For three of the datasets (Dunn, [22]
Kuijpers, [20] and Swinkels-Meewisse [23]), statistically
significant differences (p < 0.05) were found between the
c-statistics for the models using baseline pain and repeat
assessment score. A statistically significant difference in
c-statistics was found between repeat assessment score
and change in pain in two of the datasets (Swinkels-
Meewisse [23] and Van der Windt [19]). Overall, repeat
assessment of pain appeared to best predict disability
outcome.
Objective 2
In the two datasets used for objective 2 (Van der Windt
[19] and Kuijpers [20]), the number of people reporting
recovery was 53% (n = 232) in the Kuijpers [20] dataset
and 66% (n = 218) in the Van der Windt [19] dataset.
When the models (full prediction model at baseline, and
full prediction model incorporating repeat assessment of
pain) for each dataset were compared, the c-statistics in-
dicated that the addition of repeat assessment of pain
was slightly more predictive compared to the full base-
line models only, with the difference in predictive
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performance statistically significant (p < 0.05) for the
Kuijpers dataset (c-statistic 0.78, 95% CI 0.74 to 0.83 ver-
sus 0.71, 95% CI 0.67 to 0.76), but not for the Van der
Windt dataset (c-statistic 0.75, 95% CI 0.69 to 0.82 versus
0.72, 95% CI 0.66 to 0.78, see Table 3). The omnibus tests
for both datasets indicate that the addition of repeat as-
sessment of pain (Kuijpers X2(6) = 109.23, p < 0.05; van der
Windt X2(4) = 35.00, p < 0.05) to the full baseline prognostic
model significantly improve the fit of the model.
Objective 3
The purpose of this final objective was to explore the
hypothetical clinical scenario, aiming to combine opti-
mal baseline data with follow-up assessment data in a
subset of participants with uncertain prognosis, which
would make efficient use of the repeated assessment.
The full prediction model was found to provide good
prognostic performance at baseline in the Kuijpers [20]
dataset (Table 3). Table 4 shows the estimated frequen-
cies of the low, intermediate and high probability of re-
covery groups in the two stages, and their observed
outcome frequencies. Figure 1 presents the numbers in
the context of the scenario for clarity.
In stage 1, the full model at baseline presentation
leaves 229 (52%) participants in the uncertain (inter-
mediate) category. Repeat assessment of pain at six
weeks in this intermediate group reduces this number to
121 (27.4%), reclassifying an equal number to low or
high probability of recovery (n = 52 and 56 respectively)
in stage 2. These results suggest that the final combined
model is slightly better at identifying participants at high
and low probability of recovery (79% and 75% of patients
in these two groups correctly classified respectively) than
the stage 1 model. The combined model misclassifies
18% of those who did not recover (38/209 would have
been incorrectly reassured) and 15% of those who did re-
cover (35/232 would have been unnecessarily referred).
Discussion
Summary of findings
The aim of this study was to investigate whether the use
of data from repeated assessments enhanced model fit
and prognostic performance of primary care prognostic
models, in order to better predict long-term outcomes
and reduce uncertainty in clinical decision-making. Such
information can support decision making regarding the
need for monitoring symptoms, or immediate referral or
treatment. The results show that short-term repeat
assessment of pain had only slightly better prognostic
performance compared to short-term change or baseline
only scores in predicting long-term disability improvement.
Furthermore, a full baseline prediction model incorporat-
ing multiple prognostic factors does not necessarily add
prognostic value to a repeat short-term assessment of pain.
Using a hypothetical clinical scenario, combining informa-
tion from a full prediction model assessed at baseline with
Table 3 Strength of association (odds ratios, 95% CI), goodness-of-fit statistics, and discrimination for prediction models using
a baseline multivariable prognostic model versus baseline pain only, short-term change or repeat score at repeat assessment
– long-term perceived recovery as outcome
Study author Prediction model OR (95% CI) Goodness-of-fit statistics c-statistic
(95% CI)
Comparison of
c-statistics (p-value)Hosmer &
Lemeshow test
Nagelkerke
pseudo R square
Kuijpers Full model (n = 441)
Baseline pain (0–10)
Duration of complaint:
- less than 5 weeks
- 6–11 weeks
- more than 3 m
Concomitant LBP (yes/no)
Shoulder pain score at
physical examination (0–14)
Gradual onset (yes/no)
0.89 (0.82 to 0.98)*
1
0.68 (0.40 to 1.18)
0.36 (0.22 to 0.60)*
0.52 (0.32 to 0.84)*
0.96 (0.91 to 1.01)
0.60 (0.39 to 0.95)*
X2(8) = 10.45, p = 0.24 0.19 0.71 (0.67 to 0.76)
Full model plus 6w Pain
Score (n = 441)
0.72 (0.65 to 0.80)* X2(8) = 10.89, p= 0.21 0.29 0.78 (0.74 to 0.83) Full model vs. full
model plus 6w pain
score, p <0.001*
Van der
Windt
Full model (n = 282)
Baseline Pain (0–10)
Co-existing neck pain (yes/no)
Preceding trauma (yes/no)
Diagnosis Acute Bursitis
(yes/no)
0.80 (0.69 to 0.91)*
0.47 (0.27 to 0.82)*
7.44 (1.69 to 32.85)* 2.32
(1.03 to 5.20)*
X2(8) = 9.05, p = 0.34 0.17 0.72 (0.66 to 0.78)
Full model plus 4w Pain
Score (n = 270)
0.85 (0.76 to 0.95)* X2(8) = 15.07, p = 0.06 0.22 0.75 (0.69 to 0.82) Full model vs. full
model plus 4w
pain score, p = 0.10
*p < 0.05
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a brief repeat assessment of pain in only those with un-
certain prognosis at initial assessment may provide an
efficient and effective strategy towards reducing uncer-
tainty and improving discrimination between those at
high or low probability of long-term recovery from a
painful shoulder condition.
Comparison with existing literature
The results of this study do partially confirm those of
two similar studies [8, 11] which also examined the
added prognostic value of short-term monitoring on
longer-term outcomes. Dunn & Croft [11] used the same
dataset as one of those used in the present study, and
found that repeat assessment of other prognostic factors
(e.g. fear-avoidance beliefs) led to an improvement in
predictions longer-term. The similarity between this pre-
vious study and the findings from the other datasets
included here strengthens the argument that repeat as-
sessment can provide additional prognostic information
across different outcome measures. Wand et al. [8]
found that a ‘subacute profile’ (predictors measured at
six weeks) was the best at predicting long-term disability
compared to an ‘acute profile’ (baseline scores only) and
compared to change between baseline and six-week as-
sessment. Our study extended the findings of both of
these studies by testing a possible clinical scenario in
which a more efficient strategy (only re-assessing those
with uncertain prognosis rather than the entire sample)
could be applied.
The highest c-statistics obtained in objective 2 are not
as high as those reported for other prognostic models
[2–5]. For example, the STarT Back tool which can be
used to stratify patients with low back pain [24] has dem-
onstrated better prognostic performance (e.g. [25, 26]).
Variability in performance can be explained by differences
in the outcome measure used in each study (function
versus recovery), prognostic factors included in the model,
the measures used to assess prognostic factors, or differ-
ences in the study population. However, these other stud-
ies could not be used as they did not include a short-term
assessment point which we required in the present ana-
lysis. The aim of our analysis was not to find the “best”
model, but rather to find the most appropriate studies to
test our hypotheses and clinical scenario for incorporating
repeat assessment. Further research is required to confirm
whether this improvement holds for other baseline prog-
nostic models, regardless of prognostic performance.
Strengths and Limitations
This study included four relatively large (n at least 512)
datasets covering two common musculoskeletal com-
plaints. The studies included different measures of dis-
ability and used slightly different measurement time
points, but the results overall were very similar, which
gives strength to the study findings [27]. The number of
cases included in each of the analyses did differ, due to
dropout over time in each of the studies. Imputation
was considered, but a sensitivity analysis using complete
case data did not result in any significant differences in
results. The sample sizes available for each of the data-
sets included in this study did meet guidance around
numbers of cases required for building prognostic
models of an event to predictor ratio of at least 10 (e.g.
[28]), although we realise that such guidance may not be
entirely suitable for the specific analysis performed in
this study.
The inclusion of different musculoskeletal pain regions
could be considered problematic as shoulder pain prob-
lems may have a different rate of recovery, and different
prognostic factors compared to back pain problems.
However, recent cohort studies and systematic reviews
have highlighted similarities in symptom trajectories and
Table 4 Frequencies of low, intermediate and high probability of recovery and observed long-term recovery when classifying
shoulder pain patients at baseline based on the full prediction model
Hypothetical scenario Classification Frequency
n(%)
Perceived recovery at six months
Not recovered
N = 209 n(%)
Recovered
N = 232 n(%)
Stage 1 Full prediction model at baseline (n = 441) 1 – Low probability of recovery 87 (19.7) 64 (73.6) 23 (26.4)
2 – Intermediate probability of recovery 229 (51.9) 116 (50.7) 113 (49.3)
3 – High probability of recovery 125 (28.3) 29 (23.2) 96 (76.8)
Stage 1&2 Full model plus re-assessment of pain
at six weeks – Intermediate group only (n = 229)
1 – Low probability of recovery 52 (22.7) 40 (76.9) 12 (23.1)
2 – Intermediate probability of recovery 121 (52.8) 67 (55.4) 54 (44.6)
3 – High probability of recovery 56 (24.5) 9 (16.1) 47 (83.9)
Model Stage 1&2 Full model plus re-assessment
of pain at six weeks (n = 441)
1 – Low probability of recovery 87 + 52 =
139 (31.5)
64 + 40 =
104 (74.8)
23 + 12 =
35 (25.2)
2 – Intermediate probability of recovery 121(27.4) 67 (55.4) 54 (44.6)
3 – High probability of recovery 125 + 56 =
181 (41.0)
29 + 9 =
38 (21.0)
96 + 47 =
143 (79.0)
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identified generic prognostic factors across different re-
gional musculoskeletal pain problems (e.g. [6, 29, 30]).
This is supported by our findings from objective 1, con-
firming the prognostic value of short-term changes in
pain for predicting long-term disability outcomes in both
back and shoulder pain.
The included studies were selected according to spe-
cific criteria to test the present study hypothesis, but
were not systematically searched for. This means that we
may have missed additional studies that could have been
included in our analysis. However, a search of the wider
literature found that very few prognosis studies set in
primary care include a short-term assessment point,
which was a requirement for our analysis. We would how-
ever welcome further analysis of the prognostic value of
repeat pain assessment in other settings or populations.
Not every dataset could be used for analysis of each
objective. While both the Van der Windt and Kuijpers
datasets included a prognostic model, differences be-
tween these models in terms of the proportion of partic-
ipants recovered (outcome event rate) would require
different classifications for predicted probabilities in
order to address objective 3, making them difficult to
compare. Only the Kuijpers model was therefore used
for this analysis to provide an example for how such a
strategy may be used in clinical practice and how re-
searchers can investigate prognosis in the future. To
strengthen these findings, replication in other datasets
and other musculoskeletal conditions is needed, perhaps
especially because prognostic performance of the models
presented here could be considered as moderate at best.
The datasets examined here only contain patients who
consulted for musculoskeletal pain, and provided data at
both baseline and follow-up, and therefore may not be rep-
resentative of people who have musculoskeletal pain but
choose not to consult, or would not re-consult when in-
vited for a repeat assessment. The datasets included in this
study did not all take baseline assessments at the point of
consultation. As most patients are likely to consult when
their pain is at its worst, and may therefore experience a
natural reduction in pain shortly after consulting, the scores
obtained in these studies may give a different interpretation
and prognostic value than if scores were obtained during
the consultation. Studies investigating prognostic factors at
the point of care found that pain reduced shortly following
consultation, [31] suggesting that the point at which mea-
sures are taken is important and could affect the accuracy
of any prediction models derived [31].
The clinical scenario presented here does not offer
optimum prediction. However, this version of the sce-
nario (with three equal risk categories), while realistic
for this example, was meant as an illustration of this ap-
proach; it could be that different cut-off points for low,
intermediate and high probability would result in fewer
people being asked to re-consult. The choice of cut-off
point should therefore depend on clinically relevant
thresholds for treatment and referral. The number of pa-
tients in the intermediate group at baseline who needed
to return for repeat assessment was still large in our sce-
nario, highlighting the large amount of uncertainty in
the prognosis of musculoskeletal pain conditions. Similar
proportions for intermediate groups were used in the
STarT Back study, [24] which included active manage-
ment of this group rather than a ‘watch and wait’ scenario,
although in the STarT Back study these proportions were
a reflection of the patients included rather than pre-
specified proportions as in the present study. The scenario
presented here builds on this by ensuring that the low-
and high-probability groups are optimally identified, either
at first consultation or within a few weeks of that first con-
sultation. It could be that a stronger prognostic model
with better prognostic performance is needed in order to
more clearly differentiate between patients who do or do
not require referral.
The hypothetical scenario itself, while aiming to re-
duce the number of inappropriate clinical decisions, may
also lead to an increase in consultations with an impact
on GP time and costs. It could be that the single ques-
tion about pain could be asked via a phone call, SMS
text message/smart phone application 4–6 weeks after
the initial consultation, with only those who still report
pain at that point being invited back to see their GP.
Conclusions
This study investigated a clinical scenario (Fig. 1) that could
be used to help reduce the uncertainty of clinical decision-
making in GP consultations with a patient with musculo-
skeletal pain. This scenario shows a decrease in unnecessary
referrals by proposing a brief (single question), short-term
repeat assessment in those where prognosis remains uncer-
tain at the first consultation. It should also be acknowl-
edged that such a strategy has costs too, such as potential
delay in treatment, cost of repeat assessment, and the need
to have a system for combining baseline and repeat assess-
ment measures, which might make such a strategy unsuit-
able in some circumstances. However, the importance of
this study lies in its shift towards reducing uncertainty and
enabling clinicians to more confidently refer or reassure
people at an early stage using minimal information.
Prognostic models would potentially benefit from the
inclusion of short-term assessments of key prognostic
factors, in addition to baseline assessments. Further re-
search should investigate to what extent the proposed
strategy improves management compared to more exten-
sive data collection at a single point in time (baseline),
across different health conditions, in order to further test
the added value of monitoring for estimating prognosis
and optimising clinical decision making.
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